Conflict of interest statement: Disclosure The authors report no conflicts ofinterest in this work.115. Breast Cancer (Auckl). 2018 May 30;12:1178223418774802. doi:10.1177/1178223418774802. eCollection 2018.Breast Cancer Immunotherapy: An Update.Makhoul I(1), Atiq M(2), Alwbari A(1), Kieber-Emmons T(3).Author information: (1)Divisions of Hematology and Medical Oncology, Department of Internal Medicine,University of Arkansas for Medical Sciences, Little Rock, AR, USA.(2)Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.(3)Department of Pathology, University of Arkansas for Medical Sciences, LittleRock, AR, USA.The immune system plays a major role in cancer surveillance. Harnessing its powerto treat many cancers is now a reality that has led to cures in hopelesssituations where no other solutions were available from traditional anticancerdrugs. These spectacular achievements rekindled the oncology community's interestin extending the benefits to all cancers including breast cancer. The firstsection of this article reviews the biological foundations of the immune responseto different subtypes of breast cancer and the ways cancer may overcome theimmune attack leading to cancer disease. The second section is dedicated to theactual immune treatments including breast cancer vaccines, checkpoint inhibitors,monoclonal antibodies, and the "unconventional" immune role of chemotherapy.DOI: 10.1177/1178223418774802 PMCID: PMC5985550PMID: 29899661 